The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
The typical dosage is 0.25 mg subcutaneously every 20 minutes to three hours. The drug is discontinued if the maternal heart rate exceeds 120 beats/min. Terbutaline is contraindicated if the ...
21h
Zacks Investment Research on MSNFDA Expands Exelixis Cabometyx Label for Neuroendocrine TumorsExelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results